Consumers who paid for certain generic prescription drugs between May 2009 and December 2019 have until March 8, 2027, to file a claim for a share of more than $96 million in price-fixing settlements. New York Attorney General Letitia James and 47 other attorneys general announced the claims process on September 22, 2026, after a federal judge in Connecticut preliminarily approved their plan to distribute the money. The settlements cover drugs used to treat conditions including diabetes, high blood pressure, seizures and infections, many of them medications taken daily by older Americans.
How to file before the March 8, 2027 deadline
Claims can be filed online at the official settlement website, AGGenericDrugs.com, according to James’s announcement. Consumers who prefer paper can request a claim form from the claims administrator by emailing info@aggenericdrugs.com, calling the toll-free line at 1-866-290-0182 or writing to the mailing address listed on the settlement site. The same toll-free number and email address appear in announcements from the New York, New Jersey and California attorneys general, a quick way to confirm a contact is the official administrator.
“These companies inflated generic drug prices and forced hard-working families to pay excessive amounts for essential medications,” James said. “I encourage all New Yorkers who purchased eligible generic drugs to submit a claim to receive compensation.”
The claims window applies nationwide. New Jersey Attorney General Jennifer Davenport, announcing the same program, said anyone who bought a listed generic drug between May 2009 and December 2019 may be eligible. “These settlements should help consumers who are already facing out-of-control costs for prescription drugs,” Davenport said.
The deadline is the last day to submit a claim, not the day money will be paid. The court gave preliminary approval to the distribution plan, and payments follow the administrator’s review of claims. When the coalition first announced the Apotex settlement in 2025, California Attorney General Rob Bonta’s office said compensation would be determined case by case and would depend on how much each person spent on the drugs at issue.
A 2009 purchase and a 2027 deadline. Claims like this one mix a decade-long purchase window, a filing cutoff and a later payment date, and the four-date rule for reading a settlement notice sorts out which is which, in The Settlement & Refund Recovery System.
Which drugs and companies are involved
The more than $96 million comes from settlements with Apotex and Heritage, Bausch and Lannett, and Glenmark Pharmaceuticals USA. New Jersey put the total at about $96.5 million and noted that Heritage’s parent company, Emcure, is also part of the settlements. The companies agreed to cooperate in the continuing cases against other manufacturers and individual executives and to adopt reforms meant to prevent future misconduct.
The full list of eligible drugs is posted on the settlement website, and only purchases of listed drugs during the eligible period qualify. When Bonta announced the $39.1 million Apotex settlement in March 2025, his office gave examples from the list that are widely prescribed to older adults:
- Warfarin, used to prevent blood clots
- Verapamil, used to treat high blood pressure
- Glyburide-metformin, a diabetes medication
- Carbamazepine extended-release tablets, used to treat seizures
- Budesonide inhalation, used to treat asthma
- Baclofen tablets, used to treat muscle spasms
James said the drugs covered by the broader litigation span tablets, capsules, creams and ointments, and classes including antibiotics, antidepressants, contraceptives and anti-inflammatory drugs. Some coordinated price increases topped 1,000%. Digoxin, a heart medication made by Heritage, tripled in price, costing patients hundreds of dollars more, according to James’s office.
How the alleged price-fixing scheme worked
The settlements grow out of three lawsuits filed by a coalition that includes nearly every state and U.S. territory. The first, filed in 2016, named 18 companies and two individuals over 15 generic drugs. The second, filed in 2019, targeted 22 of the country’s largest generic manufacturers and 16 senior executives. The third, filed in 2020, focuses on 80 topical generic drugs and names 26 companies and 10 individuals. Davenport’s office said the states filed a fourth complaint this year against Novartis and Sandoz entities.
According to James, executives at competing companies met at industry dinners, “girls’ nights out,” lunches, cocktail parties and golf outings, and stayed in touch by phone, email and text. The complaints say they used phrases such as “fair share,” “playing nice in the sandbox” and “responsible competitor” to describe agreements to divide customers, raise prices and rig bids. Seven pharmaceutical executives are cooperating with the states.
The cases were built on evidence from several cooperating witnesses, millions of documents and a massive database of phone records, Davenport’s office said. In New York, the matter is handled by the attorney general’s Antitrust Bureau, led by Bureau Chief Elinor Hoffmann.
The claims program covers only the settling companies. The lawsuits against the remaining manufacturers and executives are still pending, so additional settlements and claims programs could follow.
Gathering records for a claim
The eligible purchases date back as far as 17 years, which makes records the biggest practical hurdle. Pharmacies can often print a prescription history for a patient, and Medicare Part D plans and private insurers send statements that show which drugs were filled and what the patient paid. Tax files can help too, since some households kept pharmacy receipts to document medical expenses. The settlement administrator’s instructions spell out what information the claim requires.
Adult children helping aging parents may want to review the list together, since a parent who took warfarin or a diabetes drug for years may not remember which generic manufacturer supplied it. Filing through the official site is free. Anyone who calls or emails offering to file a generic-drug claim in exchange for a fee or a percentage of the payment is not part of the official process, and the settlement’s contact details on AGGenericDrugs.com and state attorney general websites are the reliable way to reach the administrator.
Tracking a claim that could take months to pay
Filing for the generic-drug money is only the first step; the confirmation number, the pharmacy printouts behind the claim and the eventual payment all need to stay together until the check or deposit arrives.
The Settlement & Refund Recovery System includes a step-by-step filing walkthrough and a claim log and payment tracker, along with the scam-proof rules for telling an official administrator from a paid claim-filing pitch.
Log the claim with The Settlement & Refund Recovery System.
This article was prepared with AI assistance and reviewed against the linked official sources.
